Centre of Chronic Immunodeficiency, University Medical Centre, Freiburg, Germany.
Clin Immunol. 2010 Dec;137(3):357-65. doi: 10.1016/j.clim.2010.08.008. Epub 2010 Sep 15.
Autoimmune lymphoproliferative syndrome (ALPS) is mainly caused by defects in the CD95 pathway. Raised CD3+TCRαβ+CD4-CD8- double negative T cells and impaired T cell apoptosis are hallmarks of the disease. In contrast, the B cell compartment has been less well studied. We found an altered distribution of B cell subsets with raised transitional B cells and reduced marginal zone B cells, switched memory B cells and plasma blasts in most of 22 analyzed ALPS patients. Moreover, 5 out of 66 ALPS patients presented with low IgG and susceptibility to infection revealing a significant overlap between ALPS and common variable immunodeficiency (CVID). In patients presenting with lymphoproliferation, cytopenia, hypogammaglobulinemia and impaired B cell differentiation, serum biomarkers were helpful in addition to apoptosis tests for the identification of ALPS patients. Our observations may indicate a role for apoptosis defects in some diseases currently classified as CVID.
自身免疫性淋巴增生综合征(ALPS)主要由 CD95 通路缺陷引起。升高的 CD3+TCRαβ+CD4-CD8-双阴性 T 细胞和受损的 T 细胞凋亡是该疾病的标志。相比之下,B 细胞群的研究较少。我们发现 B 细胞亚群分布异常,过渡性 B 细胞升高,边缘区 B 细胞减少,转换记忆 B 细胞和浆母细胞增多,在分析的 22 例 ALPS 患者中大多数存在这种情况。此外,66 例 ALPS 患者中有 5 例存在 IgG 降低和易感染,这表明 ALPS 与常见可变免疫缺陷(CVID)之间存在显著重叠。在表现为淋巴增生、血细胞减少、低丙种球蛋白血症和 B 细胞分化受损的患者中,除了凋亡试验外,血清生物标志物对 ALPS 患者的识别也有帮助。我们的观察结果可能表明凋亡缺陷在某些目前归类为 CVID 的疾病中起作用。